Cleveland BioLabs Company Profile (NASDAQ:CBLI)

About Cleveland BioLabs

Cleveland BioLabs logoCleveland BioLabs, Inc. (CBLI) is a biopharmaceutical company. The Company's programs are focused developing approaches to activate the immune system and address serious medical needs. Its platform of Toll-like immune receptor activators has applications in mitigation of radiation injury and immuno-oncology. Its advanced product candidate is entolimod, an immuno-stimulatory agent, which the Company is developing as a radiation countermeasure and an immunotherapy for oncology and other indications. It also has an additional clinical-stage program and multiple projects in different stages of preclinical drug development. Its products include Entolimod, CBLB612, CBL0137 and Mobilan. Entolimod is a toll-like receptor 5 (TLR5). CBLB612 is a compound-based upon a natural activator of another tissue-specific component of the immune system. Mobilan is a recombinant non-replicating adenovirus that directs expression of TLR5.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: CBLI
  • CUSIP:
Key Metrics:
  • Previous Close: $1.65
  • 50 Day Moving Average: $1.71
  • 200 Day Moving Average: $1.70
  • 52-Week Range: $1.22 - $3.68
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -3.54
  • P/E Growth: 0.00
  • Market Cap: $18.24M
  • Outstanding Shares: 10,987,000
  • Beta: 0.82
Profitability:
  • Net Margins: -75.04%
  • Return on Equity: -21.29%
  • Return on Assets: -16.13%
Debt:
  • Current Ratio: 6.10%
  • Quick Ratio: 6.10%
Additional Links:
Companies Related to Cleveland BioLabs:

Analyst Ratings

Consensus Ratings for Cleveland BioLabs (NASDAQ:CBLI) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Cleveland BioLabs (NASDAQ:CBLI)
Show:
No equities research coverage for this company has been tracked by MarketBeat.com

Earnings

Earnings History for Cleveland BioLabs (NASDAQ:CBLI)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/15/2017        
8/15/2016Q2($0.17)ViewN/AView Earnings Details
5/16/2016Q116($0.06)ViewN/AView Earnings Details
2/22/2016Q4($0.03)ViewN/AView Earnings Details
11/5/2015Q315($0.31)$415.00 millionViewN/AView Earnings Details
8/12/2015Q215($1.12)$562.10 million$329.90 millionViewListenView Earnings Details
5/6/2015Q115($1.14)$1.33 millionViewN/AView Earnings Details
2/24/2015Q114($1.02)$3.87 million$1.39 millionViewN/AView Earnings Details
8/7/2014Q2($0.09)ViewN/AView Earnings Details
5/8/2014($0.05)($0.03)ViewN/AView Earnings Details
3/11/2014Q413($0.12)($0.01)$1.74 million$3.87 millionViewN/AView Earnings Details
11/6/2013Q313($0.14)($0.09)$1.61 million$1.60 millionViewN/AView Earnings Details
8/13/2013Q2 2013($0.16)($0.07)$1.48 million$1.60 millionViewN/AView Earnings Details
5/9/2013Q1 2013($0.17)($0.22)$1.73 million$1.37 millionViewN/AView Earnings Details
11/8/2012Q312($0.02)($0.30)$23.87 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Cleveland BioLabs (NASDAQ:CBLI)
Current Year EPS Consensus Estimate: $-0.16 EPS
Next Year EPS Consensus Estimate: $-0.48 EPS

Dividends

Dividend History for Cleveland BioLabs (NASDAQ:CBLI)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Cleveland BioLabs (NASDAQ:CBLI)
Insider Ownership Percentage: 3.21%
Institutional Ownership Percentage: 3.12%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
2/25/2015Randy S SaluckDirectorBuy1,891$3.42$6,467.22View SEC Filing  
5/21/2013Paul E DicorletoDirectorBuy6,210$1.61$9,998.10View SEC Filing  
5/17/2013Randy S SaluckDirectorBuy3,500$1.60$5,600.00View SEC Filing  
3/15/2013James AntalDirectorBuy3,700$1.56$5,772.00View SEC Filing  
9/21/2012James AntalDirectorBuy2,316$2.60$6,021.60View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Cleveland BioLabs (NASDAQ:CBLI)
DateHeadline
News IconCleveland Biolabs Inc. Reports 2016 Financial Results And Development Progress (NASDAQ:CBLI)
www.biospace.com - February 24 at 12:43 PM
biz.yahoo.com logoCLEVELAND BIOLABS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exh (NASDAQ:CBLI)
biz.yahoo.com - February 22 at 9:21 PM
finance.yahoo.com logoCleveland BioLabs Reports 2016 Financial Results and Development Progress (NASDAQ:CBLI)
finance.yahoo.com - February 22 at 4:20 PM
News IconCleveland BioLabs Inc CBLI Pharmaceuticals Healthcare Deals and Alliances Profile Prices from USD $250 (NASDAQ:CBLI)
www.bioportfolio.com - January 15 at 2:19 AM
capitalcube.com logoETFs with exposure to Cleveland BioLabs, Inc. : December 7, 2016 (NASDAQ:CBLI)
www.capitalcube.com - December 7 at 4:48 PM
News IconCleveland BioLabs, Inc. CBLI Financial and Strategic SWOT Analysis Review Prices from USD $300 (NASDAQ:CBLI)
www.bioportfolio.com - November 20 at 4:00 PM
finance.yahoo.com logoCLEVELAND BIOLABS INC Financials (NASDAQ:CBLI)
finance.yahoo.com - November 20 at 8:11 AM
News IconCleveland BioLabs, Inc. CBLI Pharmaceuticals Healthcare Deals and Alliances Profile Prices from USD $250 (NASDAQ:CBLI)
www.bioportfolio.com - November 17 at 12:31 PM
marketexclusive.com logoCleveland BioLabs, Inc. (NASDAQ:CBLI) Files An 8-K Reports Third Quarter 2016 Financial Results And Development Progress (NASDAQ:CBLI)
marketexclusive.com - November 15 at 10:22 PM
News IconCleveland Biolabs Inc. Reports Third Quarter 2016 Financial Results And Development Progress (NASDAQ:CBLI)
www.biospace.com - November 15 at 10:22 PM
capitalcube.com logoCleveland BioLabs, Inc. :CBLI-US: Earnings Analysis: Q3, 2016 By the Numbers : November 15, 2016 (NASDAQ:CBLI)
www.capitalcube.com - November 15 at 4:23 PM
publicnow.com logoCleveland BioLabs Reports Third Quarter 2016 Financial Results and Development Progress (NASDAQ:CBLI)
www.publicnow.com - November 14 at 4:13 PM
live-pr.com logoCleveland BioLabs, Inc. (CBLI) - Medical Equipment - Deals and Alliances Profile - New Market Study Published (NASDAQ:CBLI)
www.live-pr.com - November 2 at 10:46 AM
streetinsider.com logoCleveland Biolabs (CBLI) Announces $1.1M JWMRP Contract Modification with U.S. DoD (NASDAQ:CBLI)
www.streetinsider.com - October 12 at 8:37 AM
reuters.com logoBRIEF-Cleveland BioLabs announces a $1.1 mln cost realignment with Department of Defense (NASDAQ:CBLI)
www.reuters.com - October 11 at 4:13 PM
publicnow.com logoCleveland BioLabs Announces a $1.1 Million Cost Realignment With the Department of Defense (NASDAQ:CBLI)
www.publicnow.com - October 11 at 4:13 PM
capitalcube.com logoETF’s with exposure to Cleveland BioLabs, Inc. : September 28, 2016 (NASDAQ:CBLI)
www.capitalcube.com - September 28 at 3:57 PM
capitalcube.com logoETF’s with exposure to Cleveland BioLabs, Inc. : September 12, 2016 (NASDAQ:CBLI)
www.capitalcube.com - September 12 at 3:57 PM
capitalcube.com logoETF’s with exposure to Cleveland BioLabs, Inc. : August 30, 2016 (NASDAQ:CBLI)
www.capitalcube.com - August 30 at 11:57 AM
capitalcube.com logoETF’s with exposure to Cleveland BioLabs, Inc. : August 19, 2016 (NASDAQ:CBLI)
www.capitalcube.com - August 19 at 4:45 PM
capitalcube.com logoCleveland BioLabs, Inc. :CBLI-US: Earnings Analysis: Q2, 2016 By the Numbers : August 18, 2016 (NASDAQ:CBLI)
www.capitalcube.com - August 18 at 12:31 PM
News IconCleveland Biolabs Inc. Reports Second Quarter 2016 Financial Results And Development Progress (NASDAQ:CBLI)
www.biospace.com - August 17 at 12:19 PM
publicnow.com logoCleveland BioLabs Reports Second Quarter 2016 Financial Results and Development Progress (NASDAQ:CBLI)
www.publicnow.com - August 15 at 11:20 AM
biz.yahoo.com logoCLEVELAND BIOLABS INC Files SEC form 8-K, Change in Directors or Principal Officers (NASDAQ:CBLI)
biz.yahoo.com - July 22 at 4:22 PM
biz.yahoo.com logoCLEVELAND BIOLABS INC Files SEC form 8-K/A, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Sta (NASDAQ:CBLI)
biz.yahoo.com - July 21 at 6:05 AM
capitalcube.com logoETF’s with exposure to Cleveland BioLabs, Inc. : July 19, 2016 (NASDAQ:CBLI)
www.capitalcube.com - July 19 at 12:08 PM
biz.yahoo.com logoCLEVELAND BIOLABS INC Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Stand (NASDAQ:CBLI)
biz.yahoo.com - July 12 at 4:25 PM
publicnow.com logoCleveland BioLabs Announces Board Resignations (NASDAQ:CBLI)
www.publicnow.com - July 12 at 9:13 AM
fxpips.com logoServices Sector Daily Watch: Winners & Losers (NASDAQ:CBLI)
www.fxpips.com - June 22 at 8:51 AM
capitalcube.com logoCleveland BioLabs, Inc. :CBLI-US: Earnings Analysis: Q1, 2016 By the Numbers (NASDAQ:CBLI)
www.capitalcube.com - May 17 at 12:26 PM
fxpips.com logoFriday Morning’s Top Movers – UNIS, HTGM, ORMP, NVDA, CETX, CBLI, RUN (NASDAQ:CBLI)
www.fxpips.com - May 16 at 2:01 PM
publicnow.com logoCleveland BioLabs Reports First Quarter 2016 Financial Results and Development Progress (NASDAQ:CBLI)
www.publicnow.com - May 16 at 8:02 AM
bizjournals.com logo22nd Century to begin cannabis research at new medical campus labs (NASDAQ:CBLI)
www.bizjournals.com - May 12 at 2:40 PM
biz.yahoo.com logoCLEVELAND BIOLABS INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibit (NASDAQ:CBLI)
biz.yahoo.com - May 6 at 5:55 PM
biz.yahoo.com logoCLEVELAND BIOLABS INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders (NASDAQ:CBLI)
biz.yahoo.com - April 15 at 3:05 PM
publicnow.com logoCleveland BioLabs Announces Webcast of Annual Meeting (NASDAQ:CBLI)
www.publicnow.com - April 4 at 7:37 AM
rttnews.com logoGLPG Awaits SAPHIRA Data, VTAE Vaults, CBLI Hits A Snag (NASDAQ:CBLI)
www.rttnews.com - March 17 at 2:04 AM
biz.yahoo.com logoCLEVELAND BIOLABS INC Files SEC form 8-K, Other Events (NASDAQ:CBLI)
biz.yahoo.com - March 16 at 2:50 PM
finance.yahoo.com logoCleveland BioLabs Provides Update on Pre-EUA Review of Entolimod as Radiation Countermeasure (NASDAQ:CBLI)
finance.yahoo.com - March 16 at 2:00 PM
investorplace.com logoHottest Services Stocks Now – CAI NEWT INST MOBL (NASDAQ:CBLI)
investorplace.com - March 8 at 11:42 AM
biz.yahoo.com logoCLEVELAND BIOLABS INC Files SEC form 10-K, Annual Report (NASDAQ:CBLI)
biz.yahoo.com - February 23 at 5:04 PM
biz.yahoo.com logoCLEVELAND BIOLABS INC Files SEC form 8-K, Results of Operations and Financial Condition (NASDAQ:CBLI)
biz.yahoo.com - February 22 at 10:35 AM
finance.yahoo.com logoCleveland BioLabs Reports 2015 Financial Results and Development Progress (NASDAQ:CBLI)
finance.yahoo.com - February 22 at 7:30 AM
biz.yahoo.com logoCleveland BioLabs, Inc. (CBLI) (NASDAQ:CBLI)
biz.yahoo.com - February 18 at 6:31 PM
investorplace.com logoHottest Services Stocks Now – ADUS SREV EBIX CBLI (NASDAQ:CBLI)
investorplace.com - February 9 at 10:47 AM
streetinsider.com logoCleveland Biolabs (CBLI) Says Entolimod Shown to Suppress Metastasis and Induce Immunity by Stimulating NK-Dendritic-CD8+ T cell Axis (NASDAQ:CBLI)
www.streetinsider.com - February 9 at 10:47 AM
finance.yahoo.com logoEntolimod Shown to Suppress Metastasis and Induce Immunity by Stimulating NK-Dendritic-CD8+ T cell Axis in Studies by Cleveland BioLabs and Roswell Park Cancer Institute (NASDAQ:CBLI)
finance.yahoo.com - February 9 at 7:30 AM
finance.yahoo.com logoCleveland BioLabs Announces Start of Colorectal Cancer Study of Entolimod in Russian Federation (NASDAQ:CBLI)
finance.yahoo.com - February 2 at 8:00 AM
publicnow.com logoCleveland BioLabs Announces Start of Phase 2 Study of CBLB612 in Russian Federation (NASDAQ:CBLI)
www.publicnow.com - January 26 at 7:49 AM
finance.yahoo.com logoCleveland BioLabs Gets Orphan Status for Entolimod in EU (NASDAQ:CBLI)
finance.yahoo.com - January 22 at 3:25 PM

Social

What is Cleveland BioLabs' stock symbol?

Cleveland BioLabs trades on the NASDAQ under the ticker symbol "CBLI."

When will Cleveland BioLabs announce their earnings?

Cleveland BioLabs is scheduled to release their next quarterly earnings announcement on Monday, May, 15th 2017.

How do I buy Cleveland BioLabs stock?

Shares of Cleveland BioLabs can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Cleveland BioLabs stock cost?

One share of Cleveland BioLabs stock can currently be purchased for approximately $1.70.

Cleveland BioLabs (NASDAQ:CBLI) Chart for Monday, February, 27, 2017


Institutional Ownership Chart

Institutional Ownership by Quarter for Cleveland BioLabs (NASDAQ:CBLI)

Earnings History Chart

Earnings by Quarter for Cleveland BioLabs (NASDAQ:CBLI)

Dividend History Chart

Dividend Payments by Quarter for Cleveland BioLabs (NASDAQ:CBLI)

Last Updated on 2/27/2017 by MarketBeat.com Staff